Senior / Cancer / Prostate

Pluvicto extends radiographic PFS in prostate cancer subset

Posted on: Dec 5, 2022 | Posted by: Health Mag

Lutetium Lu 177 vipivotide tetraxetan improved radiographic PFS compared with androgen receptor pathway inhibitor therapy among certain men with pretreated prostate cancer...

Other Posts from Health Mag

Stockholm: a fictional take on a real-life heist still fascinates
Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer
Cassius Turvey murder trio accused of kidnapping another teen days before fatal attack
New technique offers a two-prong approach to attacking cancers
Anti-drug antibodies linked with TNF inhibitor treatment failure in noninfectious uveitis
Skip anterior cervical corpectomy, fusion seen as safe for multilevel cervical pathology
Ashton Kutcher Opens Up About "Really Painful" Pregnancy Loss With Demi Moore
This Mom's Business Plan For A "Coma Spa" Has Gone Viral
Genetic Testing in the PICU Prompts Meaningful Changes in Care
Rural infants show greater skin barrier impairment at birth than urban infants
The young woman who overcame '16 million to one' odds to survive cancer
Protected States Can Expand Access to Abortion Training
Takeaways From a Negative Trial in Biliary Tract Cancer
Time below range of 70 mg/dL can be used to estimate lower cutoff in type 1 diabetes
VIDEO: Artificial tears may benefit patients with systemic diseases
Ants show the potential to become a fast, efficient, inexpensive, and non-invasive tool for the detection of human tumors
Mine approval would march us closer to climate disaster
Tarlatamab active in recurrent small cell lung cancer
U.S. Parents Face Big Disparities in Access to Autism Care Services
More Russian sanction = World War III